We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Dynex to Market Binding Site's Workstation

By Labmedica staff writers
Posted on 17 Aug 2005
Under an expanded agreement, Dynex Technologies (Chelmsford, MA, USA) will market the DSX "walk-away” workstation of The Binding Site (Birmingham, UK).

The Binding Site will include in the workstation its full range of enzyme-linked immunosorbent assay (ELISA) kits and reagents, along with exclusive 24-hour service and support as part of a complete laboratory solution for the automation of autoimmune and infectious-disease assays.

Dynex Technologies is a leading manufacturer of microplate instrumentation incorporating advanced detection and automated sample handling, consumables, and accessories used in clinical diagnostics and biomedical research. More...


"We've very pleased to continue our long-term relationship with The Binding site as part of our strategy to partner with premier providers to expand the reach of our technologies and service clinical customers better,” stated Dr. Robert J. Rosenthal, CEO and president of Dynex. "We designed the DSX to be an open system so clinical laboratories can have the flexibility they need to run virtually any ELISA assay.”

The Binding Site specializes in the research, development, and production of immunodiagnostic kits and reagents for use in the investigation of diseases. The company has a global network of distributors.

"Now, through this expanded agreement we can better serve our customers with our entire range of autoimmune and infectious disease ELISA kits, and by providing the technical expertise to fully realize the potential of the DSX as an open-system platform,” commented Anne Grainger, vice president, sales and technical services.





Related Links:
Dynex
The Binding Site

New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Serological Pipet Controller
PIPETBOY GENIUS
New
ESR Analyzer
TEST1 2.0
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.